All News

"!-- -->

Congress is firing plenty of ammunition at pharma companies-and the regulators

For pharma to function, it needs a whole network that commands trust. The only alternative is the sort of regulation by mass tort that we've been sliding into in recent years

Americans take top spots in disease prevalence

Pharma companies must quit wasting money and get strategic when mapping out their clinical study strategies

The industry needs credibility with consumers to make a spoonful of risk go down. So how does pharma speak to top concerns?

"!-- --"

IAG Research released its top-10 list of most-recalled new pharma ads of 2007. Many familiar faces top the list, including the Nasonex bee, Abe Lincoln, and Dr. Jarvik, but how many of those faces will still be there next year?

Avenue A|Razorfish's new digital-outlook report indicates that pharma is still floundering online. Though some pharma companies are taking steps to make their online presence known, others are still crawling.

Under pressure from Congress and public scrutiny, Pfizer voluntarily pulled its controversial television campaign for Lipitor featuring Dr. Jarvik.

A new study shows that while doctors aren't in a rush to stop prescribing Vytorin, they are considering it less often as a first-line treatment option.

Baxter blood thinner has been put on ice while the Feds examine the huge increase in adverse reactions.

Pfizer's consumer ads for Lipitor are causing a stir on the blogs and in Congress. Did the company cross the line by using a famous (but unlicensed) doctor to market a drug, or is this a case of a mistaken identity?

Focused on brand integration, Area 23 launched last week with a handful of major pharma companies and a ton of ideas. The key goal--create better campaigns through stronger branding.

More and more consumers are surfing the Web for information about prescription drugs, but many bypass brand.com sites, a new report says.

Healthcare Education Services has announced details of two additional oncology specific courses to add to its comprehensive range of medical education for the pharmaceutical industry.